GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Price-to-Tangible-Book

4basebio (LSE:4BB) Price-to-Tangible-Book : 165.88 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Price-to-Tangible-Book?

As of today (2024-05-16), 4basebio's share price is £14.10. 4basebio's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was £0.09. Hence, 4basebio's Price to Tangible Book Ratio of today is 165.88.

The historical rank and industry rank for 4basebio's Price-to-Tangible-Book or its related term are showing as below:

LSE:4BB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.51   Med: 7.27   Max: 157.22
Current: 156.67

During the past 4 years, 4basebio's highest Price to Tangible Book Ratio was 157.22. The lowest was 4.51. And the median was 7.27.

LSE:4BB's Price-to-Tangible-Book is ranked worse than
99.51% of 1231 companies
in the Biotechnology industry
Industry Median: 2.81 vs LSE:4BB: 156.67

A closely related ratio is called PB Ratio. As of today, 4basebio's share price is £14.10. 4basebio's Book Value per Sharefor the quarter that ended in Jun. 2023 was £0.28. Hence, 4basebio's P/B Ratio of today is 50.90.


4basebio Price-to-Tangible-Book Historical Data

The historical data trend for 4basebio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Price-to-Tangible-Book Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
- - 7.27 17.49

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Tangible-Book Get a 7-Day Free Trial 4.51 7.27 6.71 17.49 67.65

Competitive Comparison of 4basebio's Price-to-Tangible-Book

For the Biotechnology subindustry, 4basebio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 4basebio's Price-to-Tangible-Book falls into.



4basebio Price-to-Tangible-Book Calculation

4basebio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=14.10/0.085
=165.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


4basebio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 4basebio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (LSE:4BB) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines